Bolton Securities’s Virtus Biotech ETF BBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$219K Buy
2,073
+1,230
+146% +$126K 0.01% 862
2026
Q2
$81.2K Buy
843
+528
+168% +$45.9K ﹤0.01% 1172
2026
Q1
$26.2K Sell
315
-1,000
-76% -$82.2K ﹤0.01% 1384
2025
Q4
$105K Buy
+1,315
New +$100K ﹤0.01% 980

Other funds holding BBP

Bolton Securities's BBP Position: Q3 2026 in Review

Bolton Securities increased its Virtus Biotech ETF (BBP) stake by 146% in Q3 2026, buying an estimated $126K and bringing the position to 2,073 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #862.

Bolton Securities first reported a position in BBP in Q4 2025 and has held it in 4 quarters since. 29 funds tracked by Wall St. Rank hold BBP as of Q3 2026.

  • Bolton Securities held 2,073 shares of Virtus Biotech ETF worth $219K as of Q3 2026.
  • Bolton Securities bought 1,230 Virtus Biotech ETF shares in Q3 2026, an estimated $126K.
  • Virtus Biotech ETF made up 0.01% of Bolton Securities's portfolio in Q3 2026, its #862 holding.
  • Bolton Securities first reported a position in Virtus Biotech ETF in Q4 2025 and has held it in 4 quarters since.
  • 29 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2026.

Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.